Vascular Stent Market Size, Share, Trends, Industry Analysis Report: By Technology, Product, Mode of Delivery, Material, End User (Hospitals and Cardiac Centers), and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) –

The global vascular stent market size is expected to reach USD 21.03 billion by 2034, according to a new study by Polaris Market Research. The report “Vascular Stent Market Size, Share, Trends, Industry Analysis Report: By Technology, Product, Mode of Delivery, Material, End User (Hospitals and Cardiac Centers), and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

A vascular stent is a small tube-like device inserted into blood vessels to keep them open and maintain blood flow. It is used for narrowed or blocked arteries, supporting weakened vessel walls and improving circulation.

Technological advancements in stent design, such as drug-eluting, bioresorbable, and dual therapy stents, are shaping the vascular stent market by improving patient outcomes and addressing common challenges such as restenosis. These advancements are focused on combining structural support with therapeutic benefits, providing innovative solutions to meet the evolving needs of vascular disease treatment. Drug-eluting stents gradually release medication to prevent artery re-narrowing, which has proven effective for patients with complex lesions. On the other hand, bioresorbable stents dissolve over time, providing essential structural support without leaving a permanent implant, thereby reducing long term risks. Dual therapy stents take innovation further by integrating drug release with marked anti-inflammatory or antibacterial properties, promoting faster healing and reducing the risk of infection. These innovations reflect strong market demand for safer, more effective vascular treatments that support better patient recovery and procedural success.

Manufacturers are increasingly focused on developing cost-effective stents to improve accessibility in price sensitive markets. This approach aims to make advanced cardiovascular treatments more affordable and widely available, especially in emerging regions where budget limitations often restrict healthcare access. This strategy helps companies expand their vascular stent market reach and supports healthcare providers in delivering critical interventions to underserved populations.

Vascular Stent Market Report Highlights

In terms of technology, covered stents led the vascular stent market in 2024 due to their effectiveness in preventing blood flow leakage and minimizing restenosis risk, especially in patients with complex vascular conditions.

In terms of mode of delivery, self-expanding stents are projected to register a high CAGR during the forecast period due to their durability and flexibility, which make them ideal for complex vascular anatomies.

Based on region, North America led the vascular stent market in 2024, driven by the high incidence of cardiovascular conditions, robust healthcare infrastructure, and substantial investment in research and development.

The vascular stent market in the Asia Pacific is projected to grow significantly, driven by rapid urbanization and an aging population, which contribute to an increase in lifestyle-related diseases, especially cardiovascular conditions.

A few global key market players are Medtronic, Abbott, Boston Scientific Corporation, B. Braun SE, Terumo Corporation, Biotronik, MicroPort Scientific Corporation, Koninklijke Philips N.V., and Stryker Corporation.

Polaris Market Research has segmented the vascular stent market report on the basis of technology, product, mode of delivery, material, end user, and region:

By Technology Outlook (Revenue – USD Billion, 2020–2034)

Drug-Eluting Stents

Covered Stents

Bare-Metal Stents

Bio Absorbable Stents

By Product Outlook (Revenue – USD Billion, 2020–2034)

Coronary Stents

Peripheral Stents

• Carotid Artery Stents
• Renal Artery Stents
• Femoral Artery Stents
• Iliac Artery Stents
• Other Peripheral Stents

Evar Stent Grafts

• Abdominal Aortic Aneurysm Stent Grafts
• Thoracic Aortic Aneurysm Stent Grafts

By Mode of Delivery Outlook (Revenue – USD Billion, 2020–2034)

Balloon-Expandable Stents

Self-Expanding Stents

By Material Outlook (Revenue – USD Billion, 2020–2034)

Metallic Materials

• Cobalt Chromium
• Platinum Chromium
• Stainless Steel
• Nickel Titanium

Polymer Materials

• Biodegradable Polymer
• Non-Biodegradable Polymer

By End User Outlook (Revenue – USD Billion, 2020–2034)

Hospitals

Cardiac Centers

By Regional Outlook (Revenue – USD Billion, 2020–2034)

North America

• US
• Canada

Europe

• Germany
• UK
• France
• Italy
• Spain
• Russia
• Netherlands
• Rest of Europe

Asia Pacific

• China
• India
• Japan
• South Korea
• Indonesia
• Malaysia
• Australia
• Rest of Asia Pacific

Latin America

• Argentina
• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa

• UAE
• Saudi Arabia
• Israel
• South Africa
• Rest of Middle East & Africa